Jubilant was chosen for this award for its exemplary services in the Integrated Drug Discovery and functional services business, delivering high-quality science with high efficiency for international clients that include big pharma and small biotech. The award was received by Jubilant Biosys, a Bengaluru based subsidiary of Jubilant Life Sciences Ltd.
Ms. Jayashree Aiyar, VP and Head, Discovery Biology, Jubilant Biosys receiving Bio-Excellence Award 2014 at Bangalore on behalf of Jubilant Life Sciences.
Conveying his pleasure on the award, Dr. Subir K. Basak, President, Jubilant Biosys (Global Drug Discovery Services) said, ‘It is our honor to receive the prestigious award in the category of BioServices in this highly acclaimed event. The award is an encouragement of our work in comprehensive drug discovery solutions, from target discovery to IND. The recognition motivates our team of eminent scientists to deliver the best to our partners who are large and mid-size pharma and Biotech companies.”
‘Bangalore India Bio 2014’ is India’s premier annual Biotech event renowned for calibrating the pulse of the Biotechnology industry. The event is organized by the Department of IT, BT and S & T, Government of Karnataka in association with Vision Group on Biotechnology (an apex Advisory Body headed by Dr. Kiran Mazumdar Shaw and consisting of members from both public and private sectors). The focal theme of Bangalore India Bio 2014 was "Biotech for a better tomorrow".
As part of the event, for the first time, Bio-Excellence Awards were presented to biotech leaders for their outstanding achievements in the Biotech sector. The Bio-Excellence Awardees are selected by a Jury of Industry Experts, constituted by Association of Biotechnology Led Enterprises (ABLE). The eminent Jury of Industry Experts selected winners who met three major criteria of: increase in revenue, awards and achievements received by an individual/ an institution and total number of Patents and Products.
The International Conference deliberated on issues of pressing interest to the Biotech sector including Stem Cells and Regenerative Medicine, Biosimilars, Personalised Medicine, Biomedical Devices and Digital Health, Bioinformatics for Drug Discovery & Development, Key Issues in Clinical Trials Development and Agri Biotech & Secondary Agriculture.
